CLDX Celldex Corp: Net earnings per share for the last 12 months

Public company logo of Celldex Therapeutics Inc (CLDX)

Celldex Therapeutics (CLDX) is accelerating the rollout of cancer drugs through partnerships with medical centers. The history of net income per share growth YoY ttm visualizes the dynamics of this process, where -27.20 shows the current value of the metric. The company is developing unique antibodies against urticaria while effectively utilizing external outsourcing to conduct early-stage clinical trials.

CLDX Celldex Therapeutics Inc Earnings per share for the last twelve months (02/11/2024 - 11/14/2026)

celldex.com - analytical breakdowns and key metrics (CLDX)

- market value and analyst target forecast:
Stock Quotes Celldex Therapeutics Inc|CLDX - Price Target Chart
- company stock capitalization data:
Market Valuation Celldex Therapeutics|CLDX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Celldex Therapeutics|CLDX - Company Book Value|Capitalization to Book Value Ratio celldex.com|CLDX - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Celldex Therapeutics|CLDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Celldex Therapeutics|CLDX - Company Aggregate Debts|Debts to Book Value Celldex Corp|CLDX - Company Long-Term Debt|Company Short-Term Debt Celldex Therapeutics|Quick Liquidity celldex.com
- earnings and multiples data:
CLDX - Net Profit|Net Profit Forecast Celldex Therapeutics|CLDX - P/E Multiple|Projected Price to Earnings Ratio Celldex Therapeutics|CLDX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Celldex Therapeutics|CLDX - Operating profit before deduction of amortization|Earnings per share for the trailing year Celldex Therapeutics|CLDX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months celldex.com|CLDX - Earnings growth in current year|Expected earnings per share trend next year Celldex Therapeutics
- revenue and sales details:
CLDX - Revenue and Sales Volume|Company Expected Sales Volume Celldex Therapeutics Inc|CLDX - Price-to-Revenue Ratio|Forward Price to Sales Celldex
Fundamental company valuation:CLDX, Celldex Therapeutics Inc
Core merchandise of Celldex Therapeutics

The YoY TTM net income per share growth trend reflects the efficiency of Celldex Therapeutics (CLDX) in developing monoclonal antibodies, converting clinical trial successes into shareholder value. This indicator measures the percentage change in trailing twelve-month EPS, allowing investors to assess business scaling rates and timely identify the risk of overpaying for the asset during extreme earnings peaks.

Competitor analysis

argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) protagonist-inc.com|Earnings per share for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Net earnings per one share for the last twelve months|Aurinia Corp - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris NV) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AbCellera Corp (ABCL)|Earnings per share for the last twelve months Tourmaline Bio, Inc. (TRML)|Net earnings per share for the last 12 months Precigen, Inc. PGEN|Earnings per share for the last twelve months Pharming Group NV PHAR|Net earnings per share (EPS TTM) Nektar Therapeutics Inc NKTR|Upstream Bio, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ZBIO (Zenas Biopharma, Inc.)|immunome.com (IMNM) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months gossamerbio.com (GOSS)|KALV (kalvista.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Septerna Corp|Net earnings per share (EPS TTM) PVLA|Savara Corp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Rigel Pharmaceuticals RIGL|AnaptysBio (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|ENGN (enGene) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kyvernatx.com|Earnings per share for the last twelve months Tiziana Life Sciences Ltd. (TLSA)|CABA (Cabaletta Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences VTYX|Net earnings per share for the last four quarters Theratechnologies Inc (THTX)|avalotx.com - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|AGEN (Agenus Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Climb Bio Inc.|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ImageneBio (IMA)|Shattuck Labs - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) equilliumbio.com EQ|connectbiopharm.com - Net earnings per share (EPS TTM)|immunic-therapeutics.com (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx N.V. (IFRX) - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months x4pharma.com XFOR|Net earnings per share for the last 12 months adicetbio.com (ACET)|Earnings per share for the last twelve months Celularity Inc (CELU)|Net earnings per share for the last 12 months INmune Bio Corp INMB|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|HCWB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Earnings per share for the last twelve months|ADTX: Earnings per share for the last four quarters|GRI (GRI Bio Corporation) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) XORTX Therapeutics Inc.|Earnings per share for the last twelve months Vyome Holdings (HIND)|Net earnings per share for the last four quarters revbiosciences.com|Earnings per share for the last twelve months Indaptus Therapeutics Inc INDP|Net earnings per share (EPS TTM) Scinai SCNI|CALI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AFMD|ALLK (Allakos Therapeutics) - Net earnings per share for the last 12 months|HOOKIPA - Earnings per share for the trailing year|IGMS (IGM Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iTeos Therapeutics Inc ITOS|Earnings per share for the last twelve months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TC Biopharm TCBP|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)